Published in
Taylor and Francis Group, OncoImmunology, 1(11), 2022
DOI: 10.1080/2162402x.2022.2096363
Links
Tools
Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
Journal article published in 2022 by
Raquel S. Laureano 
,
Jenny Sprooten,
Isaure Vanmeerbeerk,
Daniel M. Borras,
Jannes Govaerts,
Stefan Naulaerts ,
Zwi N. Berneman,
Benoit Beuselinck,
Kalijn F. Bol,
Jannie Borst ,
An Coosemans,
Angeliki Datsi,
Jitka Fučíková,
Lisa Kinget,
Bart Neyns
and other authors.
,
Jenny Sprooten,
Isaure Vanmeerbeerk,
Daniel M. Borras,
Jannes Govaerts,
Stefan Naulaerts ,
Zwi N. Berneman,
Benoit Beuselinck,
Kalijn F. Bol,
Jannie Borst ,
An Coosemans,
Angeliki Datsi,
Jitka Fučíková,
Lisa Kinget,
Bart Neyns
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 